The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
Certain pre-existing conditions may double, triple mortality risk for COVID-19
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke…
Young people hospitalized with COVID-19 face substantial adverse outcomes
Researchers analyzed records from 419 hospitals to study the clinical trajectories of 3,222 hospitalized COVID-19 patients aged 18-34. The researchers…
Eating disorders
Eating disorders are common, affecting 5–10% of young people, with >50% having an illness that persists for >5 years. The…
Workers With Health Insurance Face Rising Out-of-Pocket Costs
A new survey from the Kaiser Family Foundation shows annual premiums for a family now top $21,000, and deductibles have…
Workers With Health Insurance Face Rising Out-of-Pocket Costs
A new survey from the Kaiser Family Foundation shows annual premiums for a family now top $21,000, and deductibles have…
Workers With Health Insurance Face Rising Out-of-Pocket Costs
A new survey from the Kaiser Family Foundation shows annual premiums for a family now top $21,000, and deductibles have…
Quality control mechanism closes the protein production ‘on-ramps’
Recent work revealed a newfound quality control system in the protein production assembly line with possible implications for understanding neurogenerative…
Drug delivery systems to treat connective tissue disorders
A research team has devised tiny cargo-carrying systems many times smaller than a human hair, made from molecules called peptides…
New class of highly effective inhibitors protects against neurodegeneration
Neurobiologists have uncovered how a special receptor can lead to cell death. Their fundamental findings on neurodegenerative processes simultaneously led…